Clinical Study

Safety Study Of Study Drug 4 Given As A Single Intratympanic Injection In Subjects With Unilateral Meniere’S Disease

Posted Date: Jan 19, 2017

  • Investigator: Ravi Samy
  • Co-Investigator: Rebecca Reinert
  • Specialties: Otolaryngology, Audiology
  • Type of Study: Drug

The purpose of this study is to test the effectiveness and safety of OTO-104 compared to placebo in subjects with Meniere’s disease. A placebo is an inactive substance that looks like OTO-104 but does not contain active drug.OTO-104 contains an active in


You Are Being Asked To Participate In A Research Study Of An Investigational Drug, Called Oto-104, For The Symptoms Of Meniere’S Disease. An Investigational Drug Is One That Is Not Approved By The United States Food And Drug Administration (Fda).


Meniere’S Disease, Vertigo, Null, Null, Null

For More Information:

Becky Reinert

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.